Scarica l'app Stockscreener
10.19
0.00%
0.00
Dopo l'orario di chiusura:
10.19
Drugs Made In America Acquisition Ii Corp Borsa (DMII) Ultime notizie
Pfizer Inc. - Britannica
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Britannica
Catalyst Watch: Trump-Xi in DC, Meta Connect, and McDonald's Investor Day - TradingView
HVMC Stock Price, Quote & News - Syfe
Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17Donchian Channel - siam.in
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Up 0.1%Here's What Happened - MarketBeat
DMAA resets Power Analytics merger at $2.85B fixed valuation - Dealroom.co
Drugs Made In America Restructures Merger with PAGC - TipRanks
Inside the $2.85B all-stock deal for DMAA (NASDAQ: DMAA) - Stock Titan
EVOX Stock Price, Quote & News - Syfe
Affiliated (AMG) Flat at $356.19: Accumulation or Distribution Phase? 2026-09-10Regression Channel - dars.gov.et
Layoff Tracker: Merck adds 53 jobs to New Jersey chopping block - BioSpace
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times
DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACGap Down Bounce Plays - dars.gov.et
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - PR Newswire
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat
Drugs (DMIIU) Momentum: Ends Little Changed at $10.20 in the Latest Reading; Immediate View: the Supplied Trading Band Runs From $9.69 to $10.71 under the Current SnapshotMomentum Breakout Ideas - siam.in
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseMerger Arbitrage - Vinanet
DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
Amkor Technology (AMKR) Surges 3.89% to $57.75 as Advanced Packaging Demand StrengthensVWAP Breakout - careplusvn.com
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsLow Beta Factor - dars.gov.et
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilityQuality ETF - careplusvn.com
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult - Fortune
COPL|Copley Acquisition Corp|Price:10.480|Chg%:+0.010 - TradingKey
AstraZeneca falls to third-largest UK company amid US merger talks - The Guardian
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsTPO Profile - careplusvn.com
PHAR Q2 2026 Earnings: Marginal EPS Miss Triggers 15.5% SelloffCFO Commentary Report - careplusvn.com
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueIntraday Profile - careplusvn.com
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSentiment Shift - careplusvn.com
Arrow Financial Corporation Q2 2026 Earnings: EPS Surges 22% Above Estimates, Driving Modest GainsCEO Earnings Statement - careplusvn.com
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
CAII|Collective Acquisition II Ord Shs Class A|Price:9.950|Chg%:+0.010 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.130|Chg%:+0.020 - TradingKey
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.140|Chg%:+0.040 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
3.18%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):